Lymph Node Dissection for Differentiated Thyroid Cancer.

Lymph Node Dissection for Differentiated Thyroid Cancer.

Mol Imaging Radionucl Ther. 2016 Jan 05;26(Suppl 1):10-15

Authors: Mizrachi A, Shaha AR

Abstract
Lymph node metastases in differentiated thyroid cancer (DTC) have a wide spectrum of clinical significance. Several variables are taken under consideration when trying to decide on the optimal management of patients with DTC. Routine prophylactic central and/or lateral lymph node dissection is not advocated with exception of central neck dissection for locally advanced tumors. When regarding recurrent disease, foundations have been laid for clinicians to make accurate decisions as to when to perform surgery and when to continue maintaining the patient's disease under observation. These complex decisions are determined based upon multiple factors, not only regarding the patient's disease but also the patient's comprehension of the procedure and apprehension levels. Nevertheless if the patient and/or clinician are emotionally keen to surgically remove the disease then the procedure should be considered.

PMID: 28117285 [PubMed - in process]

http://ift.tt/2joRVpn